Modulation of protein kinase CK2 activity by fragments of CFTR encompassing F508 may reflect functional links with cystic fibrosis pathogenesis

Biochemistry

Volumn 47, Issue 30, 2008, Pages 7925-7936

  Pagano, Mario A ^a,b   Arrigoni, Giorgio ^a,b   Marin, Oriano ^a,b   Sarno, Stefania ^a,b   Meggio, Flavio ^a   Treharne, Kate J ^c   Mehta, Anil ^c   Pinna, Lorenzo A ^a,b  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETIAN INSTITUTE OF MOLECULAR MEDICINE   (Italy)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMERICAN CHEMICAL SOCIETY (ACS); CATALYTIC ACTIVITIES; COOPERATIVITY; CYSTIC FIBROSIS (CF); CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR); FUNCTIONAL INTERACTIONS; FUNCTIONAL LINKS; IN-VITRO; NUCLEOTIDE-BINDING DOMAIN (NBD1); POLY-LYSINE (PL); PROTEIN KINASE (PKA); PROTEIN KINASE CK2; SPR ANALYSIS; WILD-TYPE (WT);

AMINES; CHEMICAL REACTIONS; FLOW INTERACTIONS; MODULATION; NUCLEIC ACIDS; PEPTIDES; PROTEINS; SURFACE PLASMON RESONANCE;

PHOSPHORYLATION;

HOLOENZYME; NUCLEOTIDE BINDING PROTEIN; POLYLYSINE; PROTEIN KINASE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ALPHA CHAIN; ARTICLE; BETA CHAIN; CATALYSIS; CYSTIC FIBROSIS; IN VITRO STUDY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; WILD TYPE;

AMINO ACID SEQUENCE; ANIMALS; CASEIN KINASE II; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME ACTIVATION; HUMANS; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; PHOSPHOPEPTIDES; PHOSPHORYLATION; POLYLYSINE; PROTEIN BINDING; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 48249106644     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi800316z     Document Type: Article

References (42)

1. Gadsby, D. C., Vergani, P., and Csanády, L. (2006) The ABC protein turned chloride channel whose failure causes cystic fibrosis. Nature 440, 477-483.
2. Zhu, T., Hinkson, D. A., Dahan, D., Evagelidis, A., and Hanrahan, J. W. (2002) CFTR regulation by phosphorylation. Methods Mol. Med. 70, 99-109.
3. Hallows, K. R., Raghuram, V., Kemp, B. E., Witters, L. A., and Foskett, J. K. (2000) Inhibition of cystic fibrosis transmembrane conductance regulator by novel interaction with the metabolic sensor AMP-activated protein kinase. J. Clin. Invest. 105, 1711-1721.
4. Hallows, K. R., McCane, J. E., Kemp, B. E., Witters, L. A., and Foskett, J. K. (2003) Regulation of channel gating by AMP-activated protein kinase modulates cystic fibrosis transmembrane conductance regulator activity in lung submucosal cells. J. Biol. Chem. 278, 998-1004.
5. Riordan, J. R. (2005) Assembly of functional CFTR chloride channels. Annu. Rev. Physiol. 67, 701-718.
6. Short, D. B., Trotter, K. W., Reczek, D., Kreda, S. M., Bretscher, A., Boucher, R. C., Stutts, M. J., and Milgram, S. L. (1998) An apical PDZ protein anchors the cystic fibrosis transmembrane conductance regulator to the cytoskeleton. J. Biol. Chem. 273, 19797-19801.
7. Wang, S., Raab, R. W., Schatz, P. J., Guggino, W. B., and Li, M. (1998) Peptide binding consensus of the NHE-RF-PDZ1 domain matches the C-terminal sequence of cystic fibrosis transmembrane conductance regulator (CFTR). FEBS Lett. 427, 103-108.
8. Li, C., Krishnamurthy, P. C., Penmatsa, H., Marrs, K. L., Wang, X. Q., Zaccolo, M., Jalink, K., Li, M., Nelson, D. J., Schuetz, J. D., and Naren, A. P. (2007) Spatiotemporal coupling of cAMP transporter to CFTR chloride channel function in the gut epithelia. Cell 131, 940-951.
9. Sheppard, D. N., and Welsh, M. J. (1999) Structure and function of the CFTR chloride channel. Physiol. Rev. 79 (1 Suppl.), S23-S45.
10. Dalemans, W., Barbry, P., Champigny, G., Jallat, S., Dott, K., Dreyer, D., Crystal, R. G., Pavirani, A., Lecocq, J. P., and Lazdunski, M. (1991) Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation. Nature 354, 526-528.
11. Lewis, H. A., Buchanan, S. G., Burley, S. K., Conners, K., Dickey, M., Dorwart, M., Fowler, R., Gao, X., Guggino, W. B., Hendrickson, W. A., Hunt, J. F., Kearins, M. C., Lorimer, D., Maloney, P. C., Post, K. W., Rajashankar, K. R., Rutter, M. E., Sauder, J. M., Shriver, S., Thibodeau, P. H., Thomas, P. J., Zhang, M., Zhao, X., and Emtage, S. (2004) Structure of nucleotide-binding domain 1 of the cystic fibrosis transmembrane conductance regulator. EMBO J. 23, 282-293.
12. Cheng, S. H., Gregory, R. J., Marshall, J., Paul, S., Souza, D. W., White, G. A., O'Riordan, C. R., and Smith, A. E. (1990) Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 63, 827-834.
13. Qu, B. H., and Thomas, P. J. (1996) Alteration of the cystic fibrosis transmembrane conductance regulator folding pathway. J. Biol. Chem. 271, 7261-7264.
14. Gelman, M. S., and Kopito, R. R. (2002) Rescuing protein conformation: prospects for pharmacological therapy in cystic fibrosis. J. Clin. Invest. 110, 1591-1597.
15. Kälin, N., Claass, A., Sommer, M., Puchelle, E., and Tümmler, B. (1999) DeltaF508 CFTR protein expression in tissues from patients with cystic fibrosis. J. Clin. Invest. 103, 1379-1389.
16. Amaral, M. D. (2004) CFTR and chaperones: processing and degradation. J. Mol. Neurosci. 23, 41-48.
17. Lovato, V., Roesli, C., Ahlskog, J., Scheuermann, J., and Neri, D. (2007) A monoclonal antibody prevents aggregation of the NBD1 domain of the cystic fibrosis transmembrane conductance regulator. Protein Eng. Des. Sel. 20, 607-614.
18. Treharne, K. J., Crawford, R. M., Best, O. G., Schulte, E. A., Chen, J.-H., Gruenert, D. C., Wilson, S. M., Sheppard, D. N., and Mehta, A. (2005) CFTR, F508 and CK2: a novel function for the F508 residue. Ped. Pulmonol. S 28, 195.
19. Meggio, F., and Pinna, L. A. (2003) One-thousand-and-one substrates of protein kinase CK2. FASEB J. 17, 349-368.
20. Pinna, L. A. (2002) Protein kinase CK2: a challenge to canons. J. Cell Sci. 115, 3873-3878.
21. Duncan, J. S., and Litchfield, D. W. (2007) Too much of a good thing: the role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2. Biochim. Biophys. Acta 1784, 33-47.
22. Ahmad, K. A., Wang, G., Slaton, J., Unger, G., and Ahmed, K. (2005) Targeting CK2 for cancer therapy. Anticancer Drugs 16, 1037-1043.
23. Ibele, A. R., Koplin, S. A., Slaughenhoupt, B. L., Kryger, J. V., Friedl, A., and Lund, D. P. (2007) Colonic adenocarcinoma in a 13-year-old with cystic fibrosis. J. Pediatr. Surg. 42, E1-E3.
24. Treharne, K. J., Crawford, R. M., Xu, Z., Chen, J.-H., Best, O. G., Schulte, E. A., Gruenert, D. C., Wilson, S. M., Sheppard, D. N., Kunzelmann, K., and Mehta, A. (2007) Protein kinase CK2, cystic fibrosis transmembrane conductance regulator, and the ΔF508 mutation. F508 deletion disrupts a kinase-binding site. J. Biol. Chem. 282, 10804-10813.
25. Sarno, S., Vaglio, P., Meggio, F., Issinger, O.-G., and Pinna, L. A. (1996) Protein kinase CK2 mutants defective in substrate recognition. Purification and kinetic analysis. J. Biol. Chem. 271, 10595-10601.
26. Meggio, F., Donella Deana, A., and Pinna, L. A. (1981) Endogenous phosphate acceptor proteins from rat liver cytosol. J. Biol. Chem. 256, 11958-11961.
27. Fields, G. B., and Noble, R. L. (1990) Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int. J. Pept. Protein Res. 35, 161-214.
28. Thingholm, T. E., Jorgensen, T. J. D., Jensen, O. N., and Larsen, M. R. (2006) Highly selective enrichment of phosphorylated peptides using titanium dioxide. Nat. Protocols 1, 1929-1935.
29. Ruzzene, M., Brunati, A. M., Sarno, S., Donella-Deana, A., and Pinna, L. A. (1999) Hematopoietic lineage cell specific protein 1 associates with and down-regulates protein kinase CK2. FEBS Lett. 461, 32-36.
30. Perich, J. W., Meggio, F., Reynolds, E. C., Marin, O., and Pinna, L. A. (1992) Role of phosphorylated residues in generating atypical consensus sequences which are recognized by casein kinase-2 but not by casein kinase-1. Biochemistry 31, 5893-5897.
31. Pinna, L. A. (2006)Protein kinase CK2: an overview. European Cystic Fibrosis Society and The Physiological Society Joint Conference, Carvoeiro, Portugal, Abstract S6.1.
32. Donella-Deana, A., Marin, O., Cesaro, L., Gunby, R. H., Ferrarese, A., Coluccia, A. M., Tartari, C. J., Mologni, L., Scapozza, L., Gambacorti- Passerini, C., and Pinna, L. A. (2005) Unique substrate specificity of anaplastic lymphoma kinase (ALK): development of phosphoacceptor peptides for the assay of ALK activity. Biochemistry 44, 8533-8542.
33. Pagano, M. A., Sarno, S., Poletto, G., Cozza, G., Pinna, L. A., and Meggio, F. (2005) Autophosphorylation at the regulatory β subunits reflects the supramolecular organization of protein kinase CK2. Mol. Cell. Biochem. 274, 23-29.
34. Pinna, L. A., and Meggio, F. (1997) Protein kinase CK2 ("casein kinase-2") and its implication in cell division and proliferation. Prog. Cell Cycle. Res. 3, 77-97.
35. Boldyreff, B., Meggio, F., Pinna, L. A., and Issinger, O.-G. (1993) Reconstitution of normal and hyperactivated forms of casein kinase-2 by variably mutated β-subunits. Biochemistry 32, 12672-12677.
36. Meggio, F., Boldyreff, B., Issinger, O.-G., and Pinna, L. A. (1994) Casein kinase-2 down-regulation and activation by polybasic peptides are mediated by acidic residues in the 55-64 region of the β-subunit. A study with calmodulin as phosphorylatable substrate. Biochemistry 33, 4336-4342.
37. Di Maira, G., Brustolon, F., Bertacchini, J., Tosoni, K., Marmiroli, S., Pinna, L. A., and Ruzzene, M. (2007) Pharmacological inhibition of protein kinase CK2 reverts the multidrug resistance phenotype of a CEM cell line characterized by high CK2 level. Oncogene 26, 6915-6926.
38. Chang, X. B., Tabcharani, J. A., Hou, Y. X., Jensen, T. J., Kartner, N., Alon, N., Hanrahan, J. W., and Riordan, J. R. (1993) Protein kinase A (PKA) still activates CFTR chloride channel after mutagenesis of all 10 PKA consensus phosphorylation sites. J. Biol. Chem. 268, 11304-11311.
39. Wilkinson, D. J., Strong, T. V., Mansoura, M. K., Wood, D. L., Smith, S. S., Collins, F. S., and Dawson, D. C. (1997) CFTR activation: additive effects of stimulatory and inhibitory phosphorylation sites in the R domain. Am. J. Physiol. 273, L127-L133.
40. Cheng, S. H., Rich, D. P., Marshall, J., Gregory, R. J., Welsh, M. J., and Smith, A. E. (1991) Phosphorylation of the R domain by cAMP-dependent protein kinase regulates the CFTR chloride channel. Cell 66, 1027-1036.
41. Arrigoni, G., Pagano, M. A., Sarno, S., Cesaro, L., James, P., and Pinna, L. A. (2008) Mass spectrometry analysis of a protein kinase CK2β subunit interactome isolated from mouse brain by affinity chromatography. J. Proteome Res. 7, 990-1000.
42. + channel by the protein kinase CK2. J. Biol. Chem. 283, 13225-13232.